Recombinant COX2 anticorps (AA 442-572)
Aperçu rapide pour Recombinant COX2 anticorps (AA 442-572) (ABIN7875033)
Antigène
Voir toutes COX2 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 442-572
-
Fonction
- Recombinant COX2 Antibody / PTGS2
-
Purification
- Protein A affinity chromatography
-
Immunogène
- A recombinant human partial protein (amino acids 442-572) was used as the immunogen for the COX2 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant COX2 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the recombinant COX2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- COX2 (Cytochrome C Oxidase Subunit II (COX2))
-
Autre désignation
- COX2
-
Sujet
- Prostaglandins are a diverse group of autocrine and paracrine hormones that mediate many cellular and physiologic processes. Prostaglandin H2 (PGH2) is an intermediate molecule in formation of the prostaglandins. Cyclooxygenase-1 (Cox-1) and cyclooxygenase-2 (Cox-2) are prostaglandin synthases that catalyze the formation of PGH2 from arachidonic acid (AA). Cox-1 and Cox-2 are isozymes of prostaglandin-endoperoxidase synthase (PTGS). Cox-1 is constitutively expressed in most tissues and is thought to serve in general housekeeping functions. Cox-2 is efficiently induced in migratory cells responding to pro-inflammatory stimuli and is considered to be an important mediator of inflammation. Both enzymes are targets for the nonsteroidal therapeutic anti-inflammatory drugs, NSAIDs. COX2 expression is significantly increased in 85-90 % of human colorectal adenocarcinomas whereas levels of COX-1 are not changed.
-
UniProt
- P35354
-
Pathways
- Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Antigène
-